会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 13. 发明授权
    • Nitrophenyl, 10-deacetylated substituted taxol derivatives as dual
functional cytotoxic/radiosensitizers
    • 硝基苯基,10-脱乙酰基取代紫杉醇衍生物作为双功能细胞毒/放射增敏剂
    • US5780653A
    • 1998-07-14
    • US485496
    • 1995-06-07
    • Chunlin TaoNeil P. DesaiPatrick Soon-ShiongPaul A. Sandford
    • Chunlin TaoNeil P. DesaiPatrick Soon-ShiongPaul A. Sandford
    • A61K41/00C07D233/91C07D305/14C07D305/00A61K51/04C07D233/02C07D413/00
    • C07D305/14A61K41/0038
    • In accordance with the present invention, there are provided derivatives of chemotherapeutic agents (e.g., paclitaxel), which serve as bifunctional agents. Invention derivatives retain the antitumor activity of the parent compound, and, coupled with the electron affinic substituents thereon, produce compounds which show a strong capability for radiosensitizing tumor cells growing in vitro. It is expected that a single drug which combines the properties of a radiosensitizer with chemotherapeutic activity will offer significant advantages not only to patients, but also to radiotherapists seeking improved modes of treatment. The combination of antitumor properties with electron-affinic function produces novel radiosensitizers, a second generation of drugs which are more powerful to fight cancers. Bifunctional agents with the dual properties of tubulin assembly and electron affinity will make the compounds useful not only as radiosensitizers, but also as cytotoxins.
    • 根据本发明,提供了用作双功能试剂的化学治疗剂(例如紫杉醇)的衍生物。 本发明衍生物保留了母体化合物的抗肿瘤活性,并且与其上的电子亲和取代基一起产生显示出对体外生长的肿瘤细胞放射增敏的强大能力的化合物。 预期将放射增敏剂的性质与化疗活性相结合的单一药物将不仅对患者具有显着的优点,而且还将提供寻求改善治疗方式的放射治疗师的显着优点。 抗肿瘤性质与电子亲和功能的组合产生新型放射增敏剂,第二代更强大的抗癌药物。 具有微管蛋白装配和电子亲和力的双重特性的双功能试剂将使得该化合物不仅用作放射增敏剂,而且用作细胞毒素。
    • 17. 发明授权
    • Crosslinkable polypeptide compositions
    • 可交联多肽组合物
    • US06565842B1
    • 2003-05-20
    • US08484724
    • 1995-06-07
    • Soebianto A. SojomihardjoNeil P. DesaiPaul A. SandfordPatrick Soon-ShiongShubhi Nagrani
    • Soebianto A. SojomihardjoNeil P. DesaiPaul A. SandfordPatrick Soon-ShiongShubhi Nagrani
    • A61K4742
    • C12N5/0677A61K9/1652A61K9/1658A61K38/28A61K47/42A61K2035/128C07K14/4732C07K14/76C07K14/78C08F290/14C08H1/00C12N5/0671C12N11/02
    • In accordance with the present invention, there are provided rapidly crosslinkable polypeptides which are obtained upon introduction of unsaturated group(s) into the polypeptide via linkage to amino acid residues on the polypeptide directly through one of three types of linkages, namely, an amide linkage, an ester linkage, or a thioester linkage. Each of these linkages are obtainable in a single step by use of a single derivatizing agent, acrylic anhydride. Also provided are methods for preparing such modified polypeptides and various uses therefor. It has unexpectedly been found that proteins with the above-described chemical modifications have the ability to rapidly crosslink to themselves under suitable conditions. This crosslinking occurs in the absence of any external crosslinking agents (indeed, in the absence of any extraneous agents), resulting in the formation of a solid gel material. Solid crosslinked gels are formed in seconds, starting from a freely flowing solution of polypeptide. Applications of such materials are broad ranging, including the encapsulation of living cells, the encapsulation of biologically active materials, the in situ formation of degradable gels, the formation of wound dressings, the prevention of post-surgical adhesions, gene delivery, drug targetting, as a microcarrier for culture of living cells, and the like.
    • 根据本发明,提供了快速可交联的多肽,其通过直接通过三种类型的连接之一连接到多肽上的氨基酸残基而将不饱和基团引入到多肽中,即三酰胺键 ,酯键或硫酯键。 这些连接中的每一个可以通过使用单一衍生剂丙烯酸酐在一个步骤中获得。 还提供了制备这种修饰的多肽及其各种用途的方法。 意外地发现具有上述化学修饰的蛋白质具有在合适条件下快速与其自身交联的能力。 这种交联发生在没有任何外部交联剂(实际上,在没有任何外来物质的情况下)的情况下,导致形成固体凝胶材料。 固体交联凝胶在几秒钟内形成,自由流动的多肽溶液开始。 这种材料的应用范围广泛,包括活细胞的包封,生物活性材料的包封,可降解凝胶的原位形成,伤口敷料的形成,预防手术后粘连,基因递送,药物靶向, 作为活细胞培养的微载体等。